Risks for prostate cancer

Last medical review:

Some things can affect your risk, or chance, of developing cancer. Certain behaviours, substances or conditions can increase or decrease the risk. Most cancers are the result of many risks. But sometimes cancer develops in people who donʼt have any risks.

The information on this page is mainly about risks in men. There is not a lot of research on prostate cancer risk in people who are transgender, non-binary or gender-diverse. We welcome research in this area. If you are transgender or non-binary and you’re worried about your risk of prostate cancer, talk to your healthcare provider about how the information here applies to you and find out about screening in 2SLGBTQI+ communities.

The risk for prostate cancer increases as men get older. The chance of being diagnosed with prostate cancer is greater after age 50. Prostate cancer is most often diagnosed in men in their 60s.

The following can increase your risk for prostate cancer.

Family history of prostate cancer

Black ethnicity (including African or Caribbean ancestry)

Excess weight

Tall adult height

Inherited gene mutations

Family history of prostate cancer

A family history of prostate cancer means that one or more of your close blood relatives has or has had prostate cancer. Some families have more cases of prostate cancer than would be expected by chance. Sometimes it isnʼt clear whether the family’s pattern of cancer is due to chance, shared lifestyle factors, genes passed from parents to children or a combination of these factors.

Your risk of developing prostate cancer is higher if one of your first-degree relatives (your father, brother or son) has been diagnosed. The more first-degree relatives with prostate cancer that you have, the greater your risk of developing prostate cancer.

Prostate cancer risk also depends on your relative’s age at diagnosis. If your relative was diagnosed with prostate cancer before the age of 65, your chance of developing prostate cancer is higher than if your relative was diagnosed at an older age.

Black ethnicity (including African or Caribbean ancestry)

Prostate cancer occurs in Black men (including men of African or Caribbean ancestry) more often than in men of other ethnicities. Black men are also more likely to have prostate tumours that grow and spread quickly and are more likely to die from prostate cancer compared to other men.

Excess weight

Obesity or overweight increases the risk for prostate cancer. Having these conditions makes it more likely that prostate cancer will be diagnosed at a later stage. High body fat is also linked with a higher risk of developing high-grade prostate cancer.

Tall adult height

Tall men have a slightly higher risk of developing prostate cancer. The amount and type of food and drink you consume early in life affect adult height. It is thought that these are the factors that increase the risk, rather than being tall.

Inherited gene mutations

Gene mutations are changes to a gene. Some gene changes can increase the risk of developing certain types of cancer. Inherited gene mutations are passed on from a parent to a child. Only a small number of prostate cancers are caused by an inherited gene mutation. Right now, gene testing is not commonly done for prostate cancer.

The 2 most common gene mutations related to prostate cancer are HOXB13 and BRCA2. (The BRCA2 gene mutation also increases the risk for breast or ovarian cancer.) Researchers are studying many other gene mutations that may affect the risk of developing prostate cancer.

Possible risks

The following have been linked with an increased risk of prostate cancer, but more research is needed to know for sure that they are risks.

Diets high in dairy products and calcium

Diets high in dairy products and calcium may increase the risk for prostate cancer. Milk, yogurt and cheese are examples of dairy products and are also foods high in calcium.

Smoking tobacco

Some studies also show that smoking tobacco may increase the risk of being diagnosed with fast-growing (aggressive) prostate cancer or prostate cancer that has spread (metastasized) to other parts of the body. Itʼs unclear if smoking affects incidence, prognosis or both.

Inflammation of the prostate

Inflammation of the prostate is called prostatitis. Many studies, but not all, show that long-term prostatitis increases the risk of developing prostate cancer. It also makes prostate cancer grow and spread more quickly. Find out more about prostatitis.

Low blood levels of vitamin E or selenium

Having low levels of vitamin E or selenium in the blood may increase the risk of developing prostate cancer. But there isn’t enough research to show that increasing the intake of vitamin E or selenium through diet or supplements can lower the risk for prostate cancer.

Working with certain chemicals

Some evidence suggests that contact with the following chemicals may increase the risk for prostate cancer.

Pesticides used in agriculture jobs are linked with a higher risk for prostate cancer. The risk may be even higher for men with a family history of prostate cancer. Researchers donʼt know how much exposure to pesticides and which specific chemicals affect prostate cancer risk.

Cadmium is a metal known to cause cancer (called a carcinogen). Some studies show that men who have contact with cadmium in smelting or battery manufacturing industries have a higher risk of developing prostate cancer. Not all research has shown this increased risk.

Chemicals in rubber manufacturing may increase the risk for prostate cancer.

High levels of androgens

Androgens are male sex hormones that control the growth, development and function of the male reproductive system, which includes the prostate. Testosterone is the main androgen. It is naturally found in the body. It can also be taken as a treatment (called testosterone therapy) for certain conditions.

Some evidence suggests that high levels of androgens in the body are related to the development and growth of prostate cancer. More research is needed to understand the long-term effects of having high androgen levels and taking testosterone therapy.

Understanding your cancer risk

To make the decisions that are right for you, ask your doctor questions about risks. Learn how cancer can be prevented and what you can do to reduce your risk.

Expert review and references

  • Canadian Cancer Society | Société canadienne du cancer
  • Albers P, Bashir S, Mookerji N, Broomfield S, Martin AM, Ghosh S, Kinnaird A. JAMA Network Open. 2024: 7(6):e2418475.
  • Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 update on prostate cancer epidemiology and risk factors - a systematic review. European Urology. 2022: 84(2):191-206.
  • International Agency for Research on Cancer (IARC). Volume 53: Occupational Exposures in Insecticide Application, and Some Pesticides. 1991.
  • International Agency for Research on Cancer (IARC). Volume 83: Tobacco Smoke and Involuntary Smoking. 2004.
  • International Agency for Research on Cancer (IARC). Volume 96: Alcohol Consumption and Ethyl Carbamate. 2010.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 100C: Arsenic, Metals, Fibres and Dusts: A Review of Human Carcinogens. 2012.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 100F: Chemical Agents and Related Occupations: A Review of Human Carcinogens. 2012.
  • World Cancer Research Fund, American Institute for Cancer Research (AICR). Food, Nutrition, Physical Activity, and Prostate Cancer. Washington, DC: American Institute for Cancer Research (AICR); 2014.
  • National Toxicology Program. Report on Carcinogens. 15 ed. Research Triangle Park, NC: US Department of Health and Human Services, Public Health Service; 2021. https://ntp.niehs.nih.gov/whatwestudy/assessments/cancer/roc/index.html.
  • Reichert ZR, Bittencourt LK, Udager AM, Palapattu GS, Spratt DE. Cancer of the prostate. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology . 12th ed. 2023: Chapter 45.
  • Tangen CM, Neuhouser ML, Stanford JL. Prostate cancer. Thun MJ (ed.). Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018: 53:997-1018.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society